WilliamMartinCarreraMD

Clinical Trials

• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD Start of enrollment: 2021 Mar 04

  Active, not recruiting

  Phase 3

• A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy Start of enrollment: 2021 Feb 26

  Active, not recruiting

  Phase 2

• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Start of enrollment: 2020 Jun 22

  Completed

  Phase 3

• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD Start of enrollment: 2018 Dec 17

  Active, not recruiting

  Phase 1, Phase 2

• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) Start of enrollment: 2021 Jun 23

  Completed

  Phase 3

• Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye Start of enrollment: 2020 Aug 11

  Active, not recruiting

  Phase 3

• Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease Start of enrollment: 2020 Jun 29

  Active, not recruiting

  Phase 2, Phase 3

• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) Start of enrollment: 2020 Sep 30

  Terminated

  Phase 3

• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema Start of enrollment: 2020 Aug 05

  Completed

  Phase 3

• Pivotal 1 Study of RGX-314 Gene Therapy in Participants With nAMD Start of enrollment: 2020 Dec 29

  Recruiting

  Phase 2, Phase 3

• Extension Study for the Port Delivery System With Ranibizumab (Portal) Start of enrollment: 2018 Sep 20

  Recruiting

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion Start of enrollment: 2021 Mar 02

  Completed

  Phase 3

• Join now to see all